Advertisement

ECC approves $150 million grant to book COVID-19 vaccines

Advertisement

$150 million technical supplementary grant has been approved by the Economic Coordination Committee (ECC) to book coronavirus vaccines from international manufacturers.

According to the details, the decision was taken after evaluating a proposal submitted by the Ministry of National Health Services in a meeting held on Friday and chaired by Finance Advisor Dr. Abdul Hafeez Shaikh.

It was informed in the meeting that this would be the first phase of procurement and the vaccine’s amount would serve the five percent of the most vulnerable population; health workers and the population above the age of 65. The vaccine would be provided to around 10 million people covered under the above arrangement.

Furthermore, ECC had directed the ministry of national health services to discuss the proposal with the World Bank and other donors in coordination with the economic affairs division so that they can provide the financial facilities to buy the vaccine during the first phase and for the procurement of additional quantities in future as needed.

ECC also instructed the ministry to prepare a proposal regarding the pricing and risk reduction mechanism for the procurement of the coronavirus vaccine for provision on a wider scale, in consultation with the relevant stakeholders.

Advertisement

Also Read

US will not be providing COVID-19 vaccines to Pakistan in Phase-I

The United States of America (USA) has excused providing COVID-19 vaccines to...


 

Advertisement
Read More News On

Catch all the Business News, Breaking News Event and Latest News Updates on The BOL News


Download The BOL News App to get the Daily News Update & Live News.


Advertisement
End of Story
BOL Stories of the day
PM Shehbaz says no peace in world without permanent peace in Gaza
Four terrorists killed in Khyber District
KP CM challenges ECP’s notice assets case
FM Dar meets Saudi Energy Minister in Riyadh
SBP maintains policy rate at 22pc for 7th consecutive session
NICVD’s network treats over 2.4m patients annually
Next Article
Exit mobile version